SCHEMBL1775870

SCHEMBL1775870

O=C1CC[C@@H](CN2CCOCC2)N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.42
ADRA2A P08913 1/20 0.39
DRD2 P14416 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
DRD1 P21728 1/20 0.39
HTR2A P28223 1/20 0.39
HTR7 P34969 1/20 0.39
ADRA1A P35348 1/20 0.39
DRD3 P35462 1/20 0.39
OPRD1 P41143 1/20 0.39
HTR2B P41595 1/20 0.39
LMNA P02545 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
BLM P54132 1/20 0.39
DPP4 P27487 1/20 0.36
DDB1 Q16531 3/20 0.36
CRBN Q96SW2 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9865532 1.00 GAA (0.42) GAAADRA2ADRD2ADRA2BADRA2C
SCHEMBL9865525 1.00 GAA (0.42) GAAADRA2ADRD2ADRA2BADRA2C
SCHEMBL6977457 0.89 GAA (0.40) GAAADRA2ADRD2ADRA2BADRA2C
SCHEMBL1777323 0.84 CHRM5 (0.38) ADRA2COPRD1DDB1CRBN
SCHEMBL1778000 0.82 CHRM5 (0.41) ADRA2COPRD1DDB1CRBN
SCHEMBL1776075 0.82 CHRM5 (0.41) ADRA2COPRD1DDB1CRBN
SCHEMBL1776362 0.82 CHRM5 (0.41) ADRA2COPRD1DDB1CRBN
SCHEMBL27738412 0.82 CHRM5 (0.41) ADRA2COPRD1DDB1CRBN
SCHEMBL19044546 0.81 DDB1 (0.38) DDB1CRBN
SCHEMBL1777778 0.79 ACHE (0.42) DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943605-B2 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses UCB PHARMA S.A. (BE) 2011-05-17 US disclosed
US-20100305116-A1 Compounds Comprising a Cyclobutoxy Group UCB PHARMA, S.A. (BE) 2010-12-02 US disclosed
US-20100305116-A1 Compounds Comprising a Cyclobutoxy Group UCB PHARMA, S.A. (BE) 2010-12-02 US disclosed
CN-101663290-A The histamine H that comprises cyclobutoxy group 3Receptors ligand UCB PHARMA SA 2010-03-03 CN disclosed
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2009-01-22 US disclosed
WO-2008128919-A2 HISTAMINE H3 RECEPTOR LIGANDS COMPRISING A CYCLOBUTOXY GROUP UCB PHARMA S.A. (BE) 2008-10-30 WO disclosed
CN-101296902-A Compounds comprising lactam or lactam derivative moieties, processes for preparing them and their use UCB PHARMA SA (BE) 2008-10-29 CN disclosed
US-5066651-A Sulfonyl group attached to nitrogen, Alzheimer*s disease, antihypoxic, antiischemic, memory lapses ADIR ET COMPAGNIE (FR) 1991-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305116-A1 Compounds Comprising a Cyclobutoxy Group HMGCR, TECR, CYP4A11 GAA 19/4885ADRA2A 239/4885DRD2 4070/4885
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses COASY, FURIN, PEPD GAA 208/4885ADRA2A 3678/4885DRD2 3021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.